Cargando…
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
In the evolving immune-oncology landscape, numerous patients with cancer are constantly treated with immune checkpoint inhibitors (ICPIs) but among them, only sporadic cases with pre-existing hepatitis B virus (HBV) and hepatitis C virus (HCV) are recorded. Despite the global dissemination of HBV an...
Autores principales: | Ziogas, Dimitrios C, Kostantinou, Frosso, Cholongitas, Evangelos, Anastasopoulou, Amalia, Diamantopoulos, Panagiotis, Haanen, John, Gogas, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570225/ https://www.ncbi.nlm.nih.gov/pubmed/33067316 http://dx.doi.org/10.1136/jitc-2020-000943 |
Ejemplares similares
-
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
por: Ziogas, Dimitrios C, et al.
Publicado: (2020) -
Clinical considerations about the coexistence of melanoma and chronic
lymphocytic leukemia in the era of targeted therapies, triggered by rare
clinical scenarios. A case series and review of the literature
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2020) -
Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
por: Anastasopoulou, Amalia, et al.
Publicado: (2023) -
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature
por: Anastasopoulou, Amalia, et al.
Publicado: (2021) -
Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
por: Ziogas, Dimitrios C., et al.
Publicado: (2022)